After treatment was stopped, the anti-tumorigenic effects of REG were rather rapidly abrogated, but the combination of REG + aPD1 significantly prolonged tumor growth inhibition and led to sustained suppression of liver metastasis. The gene discussed is REG1A; the disease is neoplasm.